Dr. Asra AL FAUZIIndonesia
Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Academic Hospital
| 2007 to present | Chief of Neurovascular & Neuroendovascular Therapy Center - Neurosurgery Department Dr. Soetomo General Hospital, Surabaya – Indonesia |
| 2020 to present | Chairman of the Office of International Affairs of Medical Faculty, Universitas Airlangga |
| 2007 to present | Lecturer, Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga / Dr. Soetomo General Academic Hospital |
| 2011 - 2015 | Doctor of Philosophy, Universitas Airlangga, Surabaya – Indonesia |
| 2008 - 2008 | Postgraduate Neurosurgical Training, Department of Neurosurgery, Shinshu University Hospital, Matsumoto City, Japan |
| 2001 - 2007 | Neurosurgeon, Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya |
| 2011 - 2021 | Chairman of Surabaya Neuroscience Institute (SNei) |
| 2019 - 2024 | Chairman of the Standing Committee for Health of the Surabaya Chamber of Commerce and Industry (KADIN) |
| 2017 - 2019 | Senior Medical Advisor of Enigma Healthcare Singapore |
| 2020 - 2022 | Chairman of Covid-19 Controlling Task Force of the Surabaya Chamber of Commerce and Industry (KADIN) |
| - | Founder dan Chairman Brain & Spine Center Mitra Keluarga Hospital Surabaya |
Cerebrovascular Surgery and Endovascular, Skullbase Neurosurgery, Neuroscience and Stem Cell, Medical Entrepreneurship
Dr. Asra Al Fauzi is a neurosurgeon specializing in cerebrovascular, endovascular surgery, skull base neurosurgery, neuroscience, and stem cell therapy. He graduated from Universitas Airlangga and trained in Japan. He has held several prestigious positions, including President of the 20th WFNS World Neurosurgery Congress 2027, and received numerous awards, such as the 2016 AANS International Surgeon Award. He is the Chairman of the Neurovascular & Neuroendovascular Therapy Center, Dr. Soetomo General Academic Hospital in Surabaya, Indonesia. He also serves as an Associate Professor at Universitas Airlangga and is active in various national and international scientific conferences.
Stroke surgeon: The future challenging opportunities in developing countries
1108 14:35-14:45
Cerebrovascular/304B
Neurosurgical treatment of cerebrovascular diseases has experienced rapid innovation over the past three decades. The field of vascular neurosurgery combines decision-making, critical care, microsurgical skills, and advanced technology. Future challenges include minimally invasive techniques, advancements in endovascular neurosurgery, and novel strategies such as stem cell therapy and brain-computer interfaces for stroke recovery. In Indonesia, there is a need to expand neurovascular services, particularly in underserved regions. Universitas Airlangga and Dr. Soetomo General Academic Hospital are spearheading efforts to enhance stroke care nationwide through mobile endovascular teams. The increasing complexity of stroke treatments demands a new generation of neurosurgeons proficient in both surgical and endovascular procedures. Addressing the shortage of trained specialists and improving infrastructure is critical for advancing stroke care in low- and middle-income countries. Future neurosurgeons must embrace dual training in surgical and catheter-based techniques to meet these challenges and improve patient outcomes.
The future of stem cell therapy for stroke: A neurosurgical perspective
1108 16:30-16:40
Cerebrovascular/304B
Stroke remains a major cause of mortality and physical disability worldwide. Over recent decades, extensive research has been dedicated to understanding its pathological processes and developing treatments to reduce neuronal damage and enhance neurofunctional recovery post-stroke. Clinical trials involving stem cell therapy for stroke patients have been ongoing for over 15 years. These randomized controlled trials have demonstrated the safety of stem cell therapy, though its effectiveness has been limited. Currently, stem cell research for stroke is a rapidly advancing and multifaceted field. Compared to previous neuroprotective treatments, stem cell therapy for stroke offers longer windows for administration and fewer exclusion criteria for clinical indications. Nevertheless, challenges such as sourcing cells, delivery methods, required cell quantities, transplantation timing, targeted delivery to lesion sites, long-term safety and efficacy, and cell tracking persist as significant hurdles in the translational process. This review explores the latest data and advancements in stem cell therapy for stroke and examines the role of neurosurgery in current research and future applications.